Where the medicines of tomorrow are evaluated today.
CEO Nominated for Women of Influence
Linda Moore Schipani, RN, MSN, president and CEO of Clinical Research Associates, was nominated for Nashville Business Journal's 2013 Women of Influence. Forbes Magazine profile Schipani and Clinical Research Associates and its 23-year history of "bringing medical breakthroughs to market." Read the Forbes article here.
Good News from a Recent Trial
Clinical Research Associates recently conducted a clinical trial on Zostavax. This is a vaccine to prevent shingles. Formerly, Zostavax was approved only for those 60 and up. We wanted to let our participants know that Zostavax is now approved by FDA for ages 50 and up. This shows the real-world difference that clinical trials can make!
Clinical Research Associates' Dr. Greg Kyser Honored
Dr. Greg Kyser, a Nashville psychiatrist and staff physician with Clinical Research Associates, was honored by the American Psychiatric Association (APA) in March with the Warren Williams Assembly Award. Established in 1984, this award is administered by the APA Area Councils to recognize outstanding recent or current contributions in the field of psychiatry.The nomination was based on Dr. Kyser’s tireless advocacy efforts on behalf of Tennessee Psychiatric Association, the state’s leading professional organization on behavioral health.
Medical Director Dr. Stephan Sharp Named Healthcare Hero by Nashville Business Journal
Clinical Research Associates' Medical Director, Dr. Stephan Sharp, was named to the list of Healthcare Heroes by the Nashville Business Journal.